Home/ Supplements/ Omega 3/ Frutol with Full Spectrum Multivitamins

Frutol with Full Spectrum Multivitamins

product on market Liquid Pharmax Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 52% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed top ingredients consist of basic macronutrients, including fats and cholesterol, which provide energy and structural support for cells. There is strong evidence regarding the general roles of these components in human nutrition. However, the evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Frutol with Full Spectrum Multivitamins
Open Full PDF View on NIH DSLD →
Details

Label Data

1 tsp
Serving Size
60
Servings
Other Combinations
Product Type
52%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 {Calories}
Calories from Fat
15 {Calories}
Total Fat
1.5 Gram(s) (2% DV)
Saturated Fat
0.5 Gram(s) (3% DV)
Cholesterol
10 mg (3% DV)
Sodium
20 mg (1% DV)
Total Carbohydrates
2 Gram(s) (1% DV)
Sugar
1 Gram(s)
Vitamin A
1334 IU (27% DV)
Vitamin C
20 mg (33% DV)
100 IU (25% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
7.5 IU (25% DV)
Within RDA (0.3× RDA) 179 studies (A:3, B:90)
0.7 mg (47% DV)
Within RDA (0.6× RDA) 76 studies (A:0, B:33)
0.8 mg (47% DV)
Within RDA (0.6× RDA) 13 studies (A:0, B:1)
9 mg (45% DV)
Within RDA (0.6× RDA) 196 studies (A:5, B:63)
1 mg (50% DV)
Within RDA (0.8× RDA) 114 studies (A:3, B:35)
100 mcg (25% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
0.5 mcg (8% DV)
Within RDA (0.2× RDA) 139 studies (A:1, B:44)
75 mcg (25% DV)
2.5× RDA — within safe limits 27 studies (A:0, B:11)
3 mg (30% DV)
Within RDA (0.6× RDA) 2 studies — no high-quality reviews
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

concentrated Pineapple modified Corn Starch purified Water Fructose concentrated Orange Mango & Banana puree Hydroxypropyl Alginate Pineapple flavor Acacia Gum Mixed Tocopherols Vanilla flavor Sucralose Potassium Sorbate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended intake: Adults and Adolescents (9 years and older): One teaspoon (5 ml) taken two times daily with a meal or as professionally directed. Children (4-8 years): One teaspoon (5 ml) taken daily with a meal or as professionally directed. Can be taken in water or juice or directly into the mouth.

Warnings & Precautions

Keep out of reach of children.

Vacuum-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken.

Additional Information

Independently tested for PCBs, dioxins and furans, PAHs and the absence of detectable levels of mercury and other heavy metals.

Refrigerate after opening.

Pack size:

Nutriceutical & Biophysical Systems

Seroyal

Code FA43-300

Metadata

Product Details

UPC / SKU883196 20360
DSLD Entry Date2016-01-25
Product TypeOther Combinations
FormLiquid
BrandPharmax
DSLD ID55787
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.